Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2012
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitusChristine Hamann, Martina Rauner, Yvonne Höhna, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell functionGiorgio Senaldi, Marina Stolina, Jane Guo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Tumor cyclooxygenase 2-dependent suppression of dendritic cell functionSherven Sharma, Marina Stolina, Seok-Chul Yang, et al.Bone|August 6, 2014
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized ratsMarina Stolina, Denise Dwyer, Qing-Tian Niu, et al.Clinical and Experimental Rheumatology|February 14, 2012
A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune diseaseHailing Hsu, Sanjay D Khare, Frances Lee, et al.Circulation|October 29, 2020
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection FractionVirginia S Hahn, Hildur Knutsdottir, Xin Luo, et al.Endocrinology|July 8, 2011
Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized ratsXiaodong Li, Michael S Ominsky, Kelly S Warmington, et al.Bone|August 12, 2015
Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact ratsMichael S Ominsky, Danielle L Brown, Gwyneth Van, et al.Nature Medicine|January 24, 2007
Dickkopf-1 is a master regulator of joint remodelingDanielle Diarra, Marina Stolina, Karin Polzer, et al.Endocrinology|September 27, 2014
Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibodyXiaodong Li, Qing-Tian Niu, Kelly S Warmington, et al.Pageof 7